Eagle Pharmaceuticals to Present at RBC Capital Markets 2016 Global Healthcare Conference
Public Company Information:
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ:EGRX) announced today that Scott Tarriff, President and Chief Executive Officer, and David Riggs, Chief Financial Officer, will present at the RBC Capital Markets 2016 Global Healthcare Conference as follows:
|Date:||Tuesday, February 23, 2016|
|Time:||4:35 p.m. EST|
|Place:||The New York Palace Hotel, NYC|
The presentation will be webcast live at the aforementioned time, and archived for 90 days thereafter, at http://www.veracast.com/webcasts/rbc/healthcare2016/64116167106.cfm or at Company’s website at www.eagleus.com, under the Investors Section.
About Eagle Pharmaceuticals, Inc.
Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the company’s website at www.eagleus.com.